from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3057c/-

LFCtreatmentdescriptionclass of inhibitor

0.608

Amikacinug/mL Amikacintranslation

0.694

Cap5-10ug/mL Capreomycintranslation

0.979

Rox10-50 ug/mL Roxithromycintranslation

-0.266

SM2-5 ug/mL Streptomycintranslation

-1.687

Tet5-10 ug/mL Tetracyclinetranslation

1.021

Rif0.2-5ug/mL Rifampicintranscription

0.728

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.675

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.976

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.050

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.414

Clofazimine10-13 ug/mL Clofaziminerespiration

0.030

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.137

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.396

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.555

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.673

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.227

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.245

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.001

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.511

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.082

KCN5-20 ug/mL Potassium cyaniderespiration

-0.095

NaN30.2-2 mM Sodium aziderespiration

-0.041

Nigericin50 uM Nigericinrespiration

0.266

TRC10-150 ug/mL Triclosanrespiration

0.714

TRZ10-25 ug/mL Thioridazinerespiration

-0.237

Valinomycin0.5-10 uM Valinomycinrespiration

-0.345

ZnSO42 mM ZnSO4respiration

0.654

menadione6-10 ug/mL Menadionerespiration

0.378

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.171

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.250

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.452

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.012

NRP_1Non-replicating persistence stage 1dosRassociated

-0.633

Amp0.2mg/mL AmpicillincellWall

0.027

Cephalexin20-100 ug/mL CephalexincellWall

-0.018

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.281

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.265

EMB10-20 ug/mL EthambutolcellWall

0.431

Eta12-40 ug/mL EthionamidecellWall

0.169

INH0.2-0.4 ug/mL IsoniazidcellWall

0.009

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.249

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.739

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.050

BZA0.12 mg/mL BenzamidearomaticAmides

-0.303

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.352

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.299

H2O24 mM hydrogen peroxideDNAdamaging

0.334

Levo10 ug/mL LevofloxacinDNAdamaging

-1.008

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.568

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.139

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.669

UVUV-irradiationDNAdamaging

2.193

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.075

Antimycin12.5-50 ug/mL Antimycin A?

-0.009

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.169

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.632

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.046

PA8240.2-2 ug/mL PA-824?

1.703

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.543

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.331

Verapamil50 uM Verapamil?

0.713

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.235

methoxatin10-20 ug/mL Methoxatin?